We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants.
First published during the 2022 to 2024 Sunak Conservative government
Fewer poliovirus detections in London show signs of reduced community transmission but vaccine rates in some London boroughs still too low.
The legislative changes will help to make the UK one of the best countries in the world to conduct clinical research for patients and researchers.
A £27 billion tax cut for business and a trio of freezes to help families with the cost-of-living headlined the Chancellor’s Spring Budget
The MHRA’s UK Stem Cell Bank is one of only two places in the world to test this technology.
HM Treasury has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million to help bring innovative new medicines and medical technologies to UK patients more quickly.
A revolution in childcare, a £27 billion tax cut for business and a trio of freezes to help families with the cost-of-living headlined the Chancellor’s Spring Budget today, Wednesday 15 March.
Following a comprehensive scientific safety review of the latest available data on the safety of pholcodine, together with advice from the independent Commission on Human Medicines, it has been concluded that the potential r…
Following advice from the Commission on Human Medicines, the Medicines and Healthcare products Regulatory Agency (MHRA) has reclassified Cialis Together so that it can now be made available for purchase over the counter, without a prescription.…
Three members of an organised criminal gang were sentenced today (13 March 2023) at Stoke Crown Court to jail after pleading guilty to offences relating to the illegal sale of more than three million doses of prescription-on…
The MHRA is reviewing the evidence relating to the very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) associated with medicines containing pseudoeph…
This adapted COVID-19 vaccine targets both the original coronavirus (SARS-CoV-2) and the Omicron BA.4 and BA.5 sub-variants.
The medical technology strategy will ensure patients can access safe, effective and innovative equipment and medical devices.
The Minister of State at DHSC has responded to recommendations made by the Regulatory Horizons Council (RHC) on the regulation of medical devices.
The establishment of a regulatory framework for POC manufacturing would bring a range of benefits to patients, healthcare professionals and innovators.
The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that UL International UK Ltd is now designated to assess most in-vitro diagnostic (IVD) devices, increasing the UK’s capacity to process conformity assessments and ensure safe and effective IVDs reach the UK public
Horizon Scanning in the MHRA Innovation Accelerator includes a focus on the identification of Actionable Horizon Scanning Signals, but what are these, and how and why do we identify them?
Professor Tom Clutton-Brock MBE has been appointed as Chair of the Medicines and Healthcare products Regulatory Agency’s (MHRA) Interim Devices Working Group
This new vaccine, VidPrevtyn Beta, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
The Medicines and Healthcare products Regulatory Agency (MHRA) has received a total of £970,688 from BEIS’ Regulators’ Pioneer Fund for three projects that aim to unlock cutting edge regulatory innovation, to drive real world benefits for patients, the healthcare sector and clinical research…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).